Gufic BioSciences Ltd

NSE: GUFICBIO · BSE: 509079 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹422.55
Market cap: ₹4,237 Cr
Revenue (annual): ₹944.0 Cr
Net profit (annual): ₹64.21 Cr
P/E (TTM): 57.7×Sector 47.3×
Promoter holding: 72.50%+0.00% QoQ
FII holding: 0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 4 Acquisition 4 Merger & Restructuring 3 Other Announcement 2 Management Change 2 Board Meeting Outcome 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Dividend 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

31 announcements with these filters

29 Apr 2026 14:42 IST NSE

Acquisition

Gufic BioSciences Acquisition Worth ₹0.47 Cr

Gufic Biosciences Limited invested USD 50,000 (₹0.47 Crore) to acquire 3,78,350 additional shares in Australian biotech firm Selvax Pty Ltd. This strategic move aims to develop novel immunotherapy treatments for solid tumours. Following this transaction, Gufic's total holding in Selvax reached 16,85,350 shares, strengthening its oncology and biotechnology portfolio.

Value: ₹0.47 Cr

Read the filing ↗